Pharmacological potentials of Syzygium cumini: A review

Journal of the Science of Food and Agriculture

Volumn 93, Issue 9, 2013, Pages 2084-2093

  Srivastava, Shalini ^a   Chandra, Deepak ^a  

^a UNIVERSITY OF LUCKNOW   (India)

Author keywords

Antidiabetic; Antihyperlipidaemic; Antioxidant; Pharmacological; Phytochemistry; Syzygium cumini

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; PLANT MEDICINAL PRODUCT;

AFRICA; ANIMAL; BARK; CHEMISTRY; DRUG DEVELOPMENT; ETHNOPHARMACOLOGY; EUGENIA; FRUIT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INDIA; ISOLATION AND PURIFICATION; PLANT LEAF; PLANT SEED; REVIEW; SOUTHEAST ASIA;

AFRICA, EASTERN; ANIMALS; ANTIOXIDANTS; ASIA, SOUTHEASTERN; DRUG DISCOVERY; ETHNOPHARMACOLOGY; EUGENIA; FRUIT; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INDIA; PHYTOCHEMICALS; PLANT BARK; PLANT LEAVES; SEEDS;

SYZYGIUM; SYZYGIUM CUMINI; SYZYGIUM JAMBOLANA; SYZYGIUM JAMBOS;

EID: 84878704023     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.6111     Document Type: Review

References (94)

1. Sharma SB, Nasir A, Prabhu KM and Murthy PS, Anti-hyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J Ethnopharmacol 104:367-373 (2006).
2. Jagetia GC and Baliga MS, Syzygium cumini (Jamun) reduces the radiation-induced DNA damage in the cultured human peripheral blood lymphocytes: a preliminary study. Toxicol Lett 132:19-25 (2002).
3. Pepato MT, Folgado VBB, Kettelhut IC and Brunetti IL, Lack of anti-diabetic effect of a Eugenia jambolana leaf decoction on rat streptozotocin diabetes. Braz J Med Biol Res 34:389-395 (2001).
4. Pari L and Saravanan G, Antidiabetic effect of Cogent db, a herbal drug in alloxan-induced diabetes mellitus. Comp Biochem Physiol C Toxicol Pharmacol 131:19-25 (2002).
5. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD and Sujatha MB, Effect of D-400, a herbomineral preparation on lipid profile, glycated haemoglobin and glucose tolerance in streptozotocin induced diabetes in rats. Indian J Exp Biol 33:798-800 (1995).
6. CSIR, The Wealth of India, Vol. X. Council of Scientific and Industrial Research, New Delhi, pp. 100-104 (1982).
7. Williamson EM (ed.), Major Herbs of Ayurveda. Churchill Livingstone, New York, NY, pp. 279-282 (2002).
8. Kapoor LD, Handbook of Ayurvedic Medicinal Plants. CRC Press, London, pp. 179-180 (2001).
9. Sharma B, Viswanath G, Salunke R and Roy P, Effects of flavonoid rich extract from seeds of Eugenia jambolana (L.) on carbohydrate and lipid metabolism in diabetic mice. Food Chem 110:697-705 (2008).
10. Gupta DR and Agrawal SK, Chemical examination of the unsafoniable matter of the seed fat of Syzgium cumini. Sci Cult 36:298 (1970).
11. Daulatabad CMJ, Mirajkar AM, Hosamani KM and Mulla MMG, Epoxy and cyclopropenoid fatty acids in Syzygium cumini seed oil. J Sci Food Agric 43:91-94 (2006).
12. Sengupta P and Das PB, Terpenoids and related compounds. Part IV. Triterpenoids the stem-bark of Eugenia jambolana Lam. Indian Chem Soc 42:255-258 (1965).
13. Bhargava KK, Dayar R and Seshadri TR, Chemical components of Eugenia jambolana stem bark. Curr Sci 43:645-646 (1974).
14. Gupta GS and Sharma DP, Triterpenoid and other constituents of Eugenia jambolana leaves. Phytochemistry 13:2013-2014 (1974).
15. Timbola AK, Szpoganicz B, Branco A, Monache FD and Pizzolatti MG, A new flavonol from leaves of Eugenia jambolana. Fitoterapia 73:174-176 (2002).
16. Mahmoud II, Marzouk SA, Moharram FA, El-Gindi MR and Hassan AMK, Acylated flavonol glycosides from Eugenia jambolana leaves. Phytochemistry 58:1239-1244 (2001).
17. Sagrawat H, Mann AS and Kharya MD, Pharmacological potential of E. jambolana: a review. Phcog Mag 2:96-105 (2006).
18. Sridhar SB, Sheetal UD, Pai MRSM and Shastri MS, Preclinical evaluation of the anti-diabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Braz J Med Biol Res 30:463-468 (2005).
19. Singh N and Gupta M, Effects of ethanolic extract of Syzigium cumini (Linn) seed powder on pancreatic islets of alloxan diabetic rats. Indian J Exp Biol 45:861-867 (2007).
20. Chaturvedi A, Bhawani G, Agarwal PK, Goel S, Singh A and Goel RK, Anti-diabetic and anti-ulcer effects of extract of Eugenia jambolana seed in mild diabetic rats: study on gastric mucosal offensive acid-pepsin secretion. Indian J Physiol Pharmacol 53:137-146 (2009).
21. Prince PSM, Kamalakkannan N and MenonVP, Anti-diabetic and anti-hyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induced diabetic albino rats. J Ethnopharmacol 91:209-213 (2004).
22. Prince PSM, Menon VP and Pari L, Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J Ethnopharmacol 61:1-7 (1998).
23. Kumar A, Ilavarasan R, Jayachandran T, Deecaraman M, Aravindan P, Padmanabhan N, et. al., Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. J Med Plants Res 2:246-249 (2008).
24. Farswan M, Mazumder PM and Parcha V, Modulatory effect of an isolated compound from Syzigium cumini seeds on biochemical parameters of diabetic rats. Int J Green Pharm 3:128-133 (2009).
25. Sharma SB, Rajpoot R, Nasir A, Prabhu KM and Murthy PS, Ameliorative effect of active principle isolated from seeds of Eugenia jambolana on carbohydrate metabolism in experimental diabetes. Evid Based Compl Altern Med 2011:789871-879 (2011).
26. Prince PSM, Menon VP and Pari L, Effect of Syzigium cumini extracts on hepatic hexokinase and glucose-6-phosphatase in experimental diabetes. Phytother Res 11:529-531 (1997).
27. Bansal R, Ahmad N and Kidwai JR, Effect of oral administration of Eugenia jambolana seeds and chlorpropamide on blood glucose level and pancreatic cathepsin B in rats. Indian J Biochem Biophys 18:377-381 (1981).
28. Achrekar S, Kaklij GS, Pote MS and Kelkar SM, Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: mechanism of action. Vivo 5:133-148 (1991).
29. Grover JK, Vats V and Rathi SS, Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 73:461-470 (2000).
30. Lolitkar MM and Rao MRR, Pharmacology of a hypoglycemic principle isolated from the fruits of Eugenia jambolana Linn. Indian J Pharm 28:129-133 (1966).
31. Karthic K, Kirthiram KS, Sadasivam S and Thayumanavan B, Identification of α-amylase inhibitors from Syzygium cumini Linn seeds. Indian J Exp Biol 46:677-680 (2008).
32. Kunt T, Forst T, Pfutzner A, Beyer J and Wahren J, The physiological impact of proinsulin C-peptide. Pathophysiology 5:257-262 (1999).
33. Saravanan G and Pari L, Effect of Syzygium cumini bark extract on plasma and tissue glycoproteins in streptozotocin induced diabetic rats. J Cell Tissue Res 7(1):881-887 (2007).
34. Saravanan G and Leelavinothan P, Effects of Syzygium cumini bark on blood glucose, plasma insulin and C-peptide in streptozotocin induced diabetic rats. Int J Endocrinol Metabol 4:96-105 (2006).
35. Schossler DRC, Mazzanti CM, Luz SCA, Filappi A, Prestes D, Silveira AF, et al., Syzygium cumini and the regeneration of insulin positive cells from the pancreatic duct. Braz J Vet Res Anim Sci 41:236-239 (2004).
36. Lim SL, Chai JW and Kappusamy UR, Evaluation of Syzygium jambolanum methanolic leaf extract for insulin-like properties. Res J Biol Sci 3:1109-1114 (2008).
37. Rekha N, Balaji R and Deecaraman M, Effect of aqueous extract of Syzygium cumini pulp on anti-oxidant defense system in streptozotocin induced diabetic rats. Iran J Pharmacol Therapeut 7:137-145 (2008).
38. Grover JK, Yadav S and Vats V, Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 81:81-100 (2002).
39. Grover JK, Vats V, Rathi SS and Dawar R, Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J Ethnopharmacol 76:233-238 (2001).
40. Ravi K, Rajasekaran S and Subramanian S, Anti-hyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol 43:1433-1439 (2005).
41. Al-Shamaony L, Al-Khazrajoi SM and Twaij HAA, Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43:167-171 (1994).
42. Krishnakumar K, Augusti KT and Vijayammal PL, Hypolipidaemic effect of Salacia oblonga Wall. root bark in streptozotocin diabetic rats. Med Sci Res 28:65-67 (2000).
43. Elangovan V, Shohami E, Gati I and Kohea R, Increased hepatic lipid soluble antioxidant capacity as compared to other organs of streptozotocin-induced diabetic rats: a cyclic voltammetry study. Free Radic Res 32:125-134 (2000).
44. Gumieniczek A, Hopkala H, Wojtowich Z and Nikolajuk J, Changes in anti-oxidant status of heart muscle tissue in experimental diabetes in rabbits. Acta Biochim Pol 49:529-535 (2002).
45. Oberley LW, Free radicals and diabetes. Free Radic Biol Med 5:113-124 (1988).
46. Tiwari AK and Rao JM, Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci 83:30-38 (2002).
47. Brownlee M, Vlassara H and Cerami A, Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-530 (1984).
48. Baynes JW, Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412 (1991).
49. Ravi K, Ramachandran B and Subramanian S, Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol Pharmaceut Bull 27:1212-1217 (2004).
50. Bhatia IS and Bajaj KL, Chemical constituents of the seeds and bark of Syzygium cumini. Planta Med 28:346-352 (1975).
51. Nicotera P and Orrenius S, Role of thiols in protection against biological reactive intermediates. Adv Exp Med Biol 197:41-49 (1986).
52. Gregus Z, Fekete T, Halaszi E and Klaassen CD, Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoylglycine. Drug Metabol Dispos 24:682-688 (1996).
53. Dominguez C, Ruiz E, Gussinye M and Carrascosa A, Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21:1736-1742 (1998).
54. Sies H, Strategies of antioxidant defense. Eur J Biochem 215:213-219 (1993).
55. Wohaieb SA and Goldin DV, Alteration of free radical defense mechanism in streptozotocin-induced diabetic rats. Effect of insulin treatment. Diabetes 36:1014-1018 (1987).
56. McCrod JM, Keele BB and Fridovich I, An enzyme based theory of obligate anaerobiosis; the physiological functions of superoxide dismutase. Proc Natl Acad Sci USA 68:1024-1027 (1976).
57. Chance B, Greenstein DS and Roughton RJW, The mechanism of catalase action. 1. Steady state analysis. Arch Biochem Biophys 37:301-339 (1952).
58. Prince PSM, Kamalakkannan N and Menon VP, Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J Ethnopharmacol 84:205-209 (2003).
59. Ahmed F, Huded S and Malik FA, In vitro study on the radical scavenging and antilipidperoxidative effects of Eugenia jambolana aqueous extracts. J Pharm Res 3:198-200 (2010).
60. Javanmardi J, Stushnoff C, Locke E and Vivanco JM, Antioxidant activity and total phenolic content of Iranian Ocimum accessions. Food Chem 83:547-550 (2003).
61. Pizzale L, Bortolomeazzi R, Vichi S, Uberegger E and Conte LS, Antioxidant activity of sage (Salvia officinalis and S fruticosa) and oregano (Origanum onites and O indercedens) extracts related to their phenolic compound content. J Sci Food Agric 82:1645-1651 (2002).
62. Ruan ZP, Zhang LL and Lin YM, Evaluation of the antioxidant activity of Syzygium cumini leaves. Molecules 13:2545-2556 (2008).
63. Goel RK and Bhattacharya SK, Gastroduodenal mucosal defense and mucosal protective agents. Indian J Exp Biol 29:701-714 (1991).
64. Chaturvedi A, Bhawani G, Agarwal PK, Goel S, Singh A and Goel RK, Ulcer healing properties of ethanolic extract of Eugenia jambolana seed in diabetic rats: study on gastric mucosal defensive factors. Indian J Physiol Pharmacol 53:16-24 (2009).
65. Slowing K, Sollhuber M, Carretero E and Villar A, Flavonoid glycosides from Eugenia jambos. Phytochemistry 37:255-258 (1994).
66. Chaturvedi A, Kumar MM, Bhawani G, Chaturvedi H, Kumar M and Goel RK, Effect of ethanolic extract of Eugenia jambolana seeds on gastric ulceration and secretion in rats. Indian J Physiol Pharmacol 51:131-140 (2007).
67. Thapa BR and Walia A, Liver function tests and their interpretation. Indian J Pediatr 74:663-671 (2007).
68. Murugesh KS, Yeligar VC, Maiti BC and Maity TP, Hepatoprotective and antioxidant role of Berberis tinctoria Lesch leaves on paracetamol induced hepatic damage in rats. Iran J Pharmacol Therapeut 4:64-69 (2005).
69. Evans WC, Trease and Evans' Pharmacognosy (15th edn). Elsevier, Philadelphia, PA, pp. 214-252 (2002).
70. Das S and Sarme G, Study of the hepatoprotective activity of the ethanolic extract of the pulp of Eugenia jambolana (Jamun) in albino rats. J Clin Diagn Res 3:1466-1474 (2009).
71. Brito FA, Lima LA, Ramos MFS, Nakamura MJ, Cavalher-Machado SC, Siani AC, et al., Pharmacological study of anti-allergic activity of Syzygium cumini (L.) Skeels. Braz J Med Biol Res 40:105-115 (2007).
72. Middleton E, Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 439:175-182 (1998).
73. Mahapatra PK, Chakraborty D and Chaudhari AKN, Anti-inflammatory and antipyretic activities of Syzygium cumini. Planta Med 6:540 (1986).
74. Kumar EK, Mastan SK, Reddy KR, Reddy GA, Raghunandan N and Chaitanya G, Anti-arthritic property of methanolic extract of Syzygium cumini seeds. Int J Integr Biol 4:55-61 (2008).
75. Shukla M, Consumption of hydrolysable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition 24:733-743 (2008).
76. Hirano T, Arimitsu J, Higa S, Naka T, Ogata A, Shima Y, et al., Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils. Int Arch Allergy Immunol 140:150-156 (2006).
77. Djipa CD, Delmee M and Quetin-Leclercq J, Antimicrobial activity of bark extracts of Syzygium jambos (L.) Alston (Myrtaceae). J Ethnopharmacol 71:307-313 (2000).
78. Shafia PM, Rosamma MK, Jamil K and Reddy PS, Antibacterial activity of Syzygium cumini and Syzygium travancoricum leaf essential oils. Fitoterapia 73:414-416 (2002).
79. Abalea V, Cillard J, Dubos MP, Sergent O, Cillard P and Morel I, Repair of iron induced DNA oxidation by the flavonoid myricetin in primary rat hepatocyte culture. Free Radic Biol Med 26:1457-1466 (1999).
80. Theresiamma KC, George J and Kuttan R, Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 34:845-847 (1996).
81. Kumar A, Padmanabhan N and Krishana MRV, Central nervous system activity of Syzigium cumini seeds. Pak J Nutr 6:698-700 (2007).
82. Tripathi KD, Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers, New Delhi, pp. 797-807 (2008).
83. Mukherjee PK, Saha K, Murugesan T, Mandal SC, Pal M and Saha BP, Screening of anti-diarrhoeal profile of some plant extracts of a specific region of West Bengal, India. J Ethnopharmacol 60:85-89 (1998).
84. Tanwar RS, Sharma SB, Singh UR and Prabhu KM, Attenuation of renal dysfunction by anti-hyperglycemic compound isolated from fruit pulp of Eugenia jambolana in streptozotocin induced diabetic rats. Indian J Biochem Biophys 47:83-89 (2010).
85. Kumar A, Ilavarasan R, Jayachandran T, Deecaraman M, Kumar RM, Aravindan P, et al., Anti-inflammatory activity of Syzygium cumini seed. Afr J Biotechnol 7:941-943 (2008).
86. Rajasekaran M, Bapna JS, Lakshmanan S, Ramchandran Nair AG, Veliath AJ and Panchanadam M, Antifertility effect in male rats of oleanolic acid, a triterpene from Eugenia jambolana flowers. J Ethnopharmacol 24:115-121 (1988).
87. Namba TM, Tsunezuka NK, Dissanayake UP and Hattori M, Studies on dental caries prevention by traditional medicines. Part VII. Screening of Ayurvedic medicines for anti-plaque action. Shoyakugaku Zasshi 39:146-153 (1985).
88. Mokkhasmit M, Swasdimongkol K, Ngarmwathana W and Permphiphat U, Pharmacological evaluation of Thai medicinal plants. J Med Assoc Thai 54:490-504 (1971).
89. Singh R, Inactivation of potato virus X by plant extracts. Phytopathol Mediterr 10:211-213 (1971).
90. DuPont MS, Day AJ, Bennett RN, Mellon FA and Kroon PA, Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr 58:947-954 (2004).
91. Manach C, Williamson G, Morand C, Scalbert A and Remesy C, Bioavailability and bioefficacy of polyphenols in humans. Am J Clin Nutr 81:230S-242S (2005).
92. Bopp A, De Bona KS, Belle LP, Moresco RN and Moretto MB, Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients. Fund Clin Pharmacol 23:501-507 (2009).
93. Chandra D, Jackson EB, Ramana KV, Kelley R, Srivastava SK and Bhatnagar A, Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes 51:3095-3101 (2002).
94. Kumar A, Singh AK, Gautam AK, Chandra D, Singh D, Changkija B, et al., Identification of kaempferol regulated proteins in rat calvarial osteoblasts during mineralization by proteomics. Proteomics 10:1730-1739 (2010).